{
    "2018-03-19": [
        [
            {
                "time": "",
                "original_text": "[推荐评级]医药行业周报：医改新猜想 行业新机会",
                "features": {
                    "keywords": [
                        "医药",
                        "医改",
                        "新猜想",
                        "行业新机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]医药生物行业周报：医药行业迎来全新发展机遇",
                "features": {
                    "keywords": [
                        "医药生物",
                        "全新发展",
                        "机遇"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药生物行业研究周报：医药部委体系调整 改革箭在弦上",
                "features": {
                    "keywords": [
                        "医药生物",
                        "部委体系",
                        "调整",
                        "改革"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[领先大市-A评级]医药行业每周观点：把握结构性机会 短中期密切关注业绩超预期和年报业绩落地支撑盈利向上的个股",
                "features": {
                    "keywords": [
                        "医药",
                        "结构性机会",
                        "业绩超预期",
                        "年报业绩",
                        "盈利向上"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}